tiprankstipranks
Trending News
More News >
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC

Cartesian Therapeutics (RNAC) Revenue

Compare
1,109 Followers

Cartesian Therapeutics Revenue

Cartesian Therapeutics had a revenue of -759.00K in the quarter ending Dec 31, 2024, with -296.12%. This bring the company's revenue in the last twelve months to 38.91M, Increased -18.83%. In the fiscal year ending Dec 31, 2024, Cartesian Therapeutics had annual revenue of 38.91M with 49.64% growth.
Revenue (ttm)
38.91M
Revenue Growth
38.82%
P/S Ratio
6.11
Revenue/Employee
$589,591
Employees
66
Market Cap
$237.74M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
38.91M12.91M+49.64%
Dec 31, 2023
26.00M-84.77M-76.53%
Dec 31, 2022
110.78M25.70M+30.21%
Dec 31, 2021
85.08M68.48M+412.60%
Dec 31, 2020
16.60M9.92M+148.57%
Dec 31, 2019
6.68M5.77M+639.42%
Dec 31, 2018
903.00K696.00K+336.23%
Dec 31, 2017
207.00K-7.88M-97.44%
Dec 31, 2016
8.08M2.07M+34.47%
Dec 31, 2015
6.01M2.97M+97.73%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis